CHARLOTTE HU: Open Payments
NPI 1093016735 · STUDIO CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,525 in 139 payments from 23 companies in 2025. Trend: 2023 $1,795 · 2024 $2,238 · 2025 $2,525
Food & beverage: $2,525
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $440 |
| Regeneron Healthcare Solutions, Inc. | 13 | $280 |
| Janssen Biotech, Inc. | 14 | $276 |
| UCB, Inc. | 11 | $229 |
| LEO Pharma Inc. | 12 | $179 |
| Galderma Laboratories, L.P. | 14 | $164 |
| Incyte Corporation | 12 | $164 |
| GENZYME CORPORATION | 5 | $163 |
| Lilly USA, LLC | 9 | $140 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $117 |
Products named: DUPIXENT, RINVOQ, TREMFYA, Bimzelx, OPZELURA, SKYRIZI, ANZUPGO, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
